Most conversations about vitamin K2 focus on how much you should take, not when you should take it. But timing has become an increasingly interesting question as scientists learn more about the body’s internal clock. Bone tissue isn’t repaired at a constant rate throughout the day as it follows a circadian rhythm, with key processes becoming more active during the night. This raises an intriguing possibility that could the timing of your vitamin K2 supplement influence how effectively it supports bone health?
Bone isn’t a fixed structure sitting quietly in your body. It’s constantly being broken down and rebuilt, and that cycle isn’t random as it follows a daily pattern. A 2023 review that pooled 29 studies on this exact question found a clear circadian rhythm in the key markers of bone activity, including osteocalcin, the protein vitamin K2 is best known for activating. Most of these markers, for both bone breakdown and bone building, peak at night or in the early morning hours (Diemar et al., 2023). If that’s when the demand for active osteocalcin is highest, it’s a reasonable question to ask whether the supply of vitamin K2 should be timed to match it.
What Happens When You Test Timing
It’s easy to think that taking anything for bone health at night must always be better, but research shows that it’s not that simple.
In one study, researchers gave 50 women with osteoporosis a medicine called teriparatide, which helps the body build new bone. Half of the women took it every morning, while the other half took it every evening. They continued this for one year.
At the end of the study, the women who took the medicine in the morning had a greater increase in bone density in their spine than those who took it in the evening (Michalska et al., 2012).
Does this mean everyone should take vitamin K2 in the morning? Not necessarily.
The important thing to remember is that teriparatide and vitamin K2 work in completely different ways. Teriparatide is a medication that stimulates bone formation by affecting the body’s natural hormone signals, which change throughout the day. Whereas Vitamin K2 is a nutrient that helps activate proteins involved in directing calcium to the bones. It doesn’t work through the same hormone pathway.
So, the study doesn’t prove that morning is better for vitamin K2. Instead, it teaches us an important lesson: the best time to take a bone-health treatment depends on how that treatment works. We can’t assume that “nighttime is always better” or “morning is always better” for every product.
In simple terms, timing isn’t one-size-fits-all. Different bone treatments behave differently in the body, so recommendations should be based on evidence for that specific treatment, not on a general belief that one time of day is always superior. (Michalska et al., 2012).
Why MK-7 Complicates the “Take It at Night” Argument
Many people recommend taking vitamin K2 at night because bone-building activity increases while we sleep. At first, this sounds like a good idea. However, MK-7 behaves differently from other forms of vitamin K2, making the timing less important than many people think.
The reason has to do with how long MK-7 stays in the body.
Some forms of vitamin K2, such as MK-4, are cleared from the bloodstream quite quickly. For these short-lasting forms, taking the supplement close to the time when the body needs it most, such as during nighttime bone remodeling could make a noticeable difference.
MK-7 is different. A study found that after taking just one dose, MK-7 remained detectable in the bloodstream for up to 48 hours (Sato et al., 2012). In other words, if you take MK-7 every day, some of yesterday’s dose and even part of the dose from the day before is still present in your blood.
Because MK-7 stays in the body for such a long time, there is a steady supply available throughout the day and night. This means you don’t have to take it at a specific hour for it to be present when your bones are being remodeled during sleep.
So, while the idea of taking supplements at night is based on real biology, it is a much stronger argument for short-acting forms like MK-4 than for long-lasting MK-7.
In simple terms, imagine watering a plant. If you give it only a small splash that dries up quickly, the timing of watering matters a lot. But if you use a slow-release watering system that keeps the soil moist for two days, the exact time you turn it on becomes much less important. MK-7 works more like the slow-release system as it stays in your body long enough that consistency is likely more important than taking it at a particular time. (Sato et al., 2012)
What is the best time to take MK-7?
The most honest answer is that we don’t know for certain yet.
The idea of taking MK-7 at night is based on good scientific reasoning, but it has not been directly proven. So far, researchers have not conducted a study where one group takes MK-7 in the morning and another takes it at night, then compares their bone or heart health over time.
What we do know is this:
- Bone remodeling is more active at night, so there is a biological reason to think evening supplementation might be beneficial.
- MK-7 stays in the body for a long time i.e. up to about 48 hours after a single dose. This means it is present in your bloodstream throughout the day and night, making the exact time you take it less important than with shorter-acting nutrients.
- MK-7 is fat-soluble, so it is absorbed better when taken with a meal that contains some healthy fat.
Because of these facts, consistency is likely more important than the specific time on the clock.
If taking MK-7 with dinner or in the evening helps you build a daily habit, that’s a reasonable choice because it aligns with the body’s nighttime bone activity. On the other hand, if you’re more likely to remember it with breakfast or lunch, that’s perfectly acceptable too. A supplement only works if you take it regularly.
In simple terms, there is some scientific support for taking MK-7 in the evening, but there is no direct evidence proving it is better than taking it in the morning. Until such studies are done, the best approach is to take MK-7 consistently every day with a meal that contains some fat, at whatever time you can stick to most reliably.
Where TerraQuino Comes In
For brands formulating K2 products, this research points to a practical takeaway more than a marketing hook because MK-7 stays active in the body for days rather than hours, a well-made MK-7 ingredient gives the end consumer more flexibility, not less.
TerraQuino produces MK-7 through a controlled fermentation process, delivering long-chain, allergen-free vitamin K2-7 built around that longer-lasting profile.
It’s formulated for tablets, capsules, softgels, sachets, and liquids, giving formulators a consistent ingredient to build daily-use products around, whatever time of day the end consumer prefers.
Frequently Asked Questions
Is there an actual study that tested morning versus night vitamin K2?
Not yet, for K2 specifically. The circadian case is built from real research on bone marker rhythms (Diemar et al., 2023) and vitamin K2 bioavailability (Sato et al., 2012), not from a direct head-to-head timing trial.
Does taking K2 at night interfere with sleep?
There’s no research indicating vitamin K2 is stimulating in the way caffeine is. Most people who take it in the evening report no effect on sleep either way.
Should I take K2 with dinner instead of breakfast?
Since K2 is fat-soluble, its better to take it together with the meal having the highest percentage of fat.
Does the timing question matter more for MK-4 than MK-7?
Considering the difference in bioavailability between the two versions of vitamin K2, the answer is yes; the former being a short-acting form should be taken at a specific time as opposed to the latter (long-acting form) to coincide with high bone activity during night (Sato et al., 2012).
References
Diemar, S. S., Dahl, S. S., West, A. S., Simonsen, S. A., Iversen, H. K., & Jørgensen, N. R. (2023). A systematic review of the circadian rhythm of bone markers in blood. Calcified Tissue International, 112(2), 126–147. https://doi.org/10.1007/s00223-022-00965-1
Michalska, D., Luchavova, M., Zikan, V., Raska, I., Jr., Kubena, A. A., & Stepan, J. J. (2012). Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis. Osteoporosis International, 23(12), 2885–2891. https://doi.org/10.1007/s00198-012-1955-4
Sato, T., Schurgers, L. J., & Uenishi, K. (2012). Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutrition Journal, 11, Article 93. https://doi.org/10.1186/1475-2891-11-93
